StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Specialty Care Portfolio Total [legacy] by Year

Specialty Care Portfolio Total [legacy] — International ($M) ($M)

QuarterlyAnnual

Pfizer Specialty Care Portfolio Total [legacy]: $9,249M in FY2025, up 6.7% from a year earlier.

Latest, FY2025
9,249
Period ended Dec 31, 2025
Change on a year earlier
+6.7%
8,671 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below

Where the FY2025 figure comes from

“|| Specialty Care | $ | 17,546 | $ | 16,652 | 5% | 5% | $ | 8,297 | $ | 7,981 | 4% | $ | 9,249 | $ | 8,671 | 7% | 6%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Care Portfolio Total [legacy] — International ($M) ($M)Year on yearSource
FY2025Dec 31, 20259,249+6.7%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2024Dec 31, 20248,671+3.6%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2023Dec 31, 20238,370+109.6%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2022Dec 31, 20223,994+3.8%Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2021Dec 31, 20213,849–Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗

Cite this data

StockData. (2026). Pfizer Specialty Care Portfolio Total [legacy] ($M), annual FY2021–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/port-leg-sc-intl

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.